Novo Integrated Sciences, Inc. Appoints Sterling Jimenez, Ph.D., as the Principal Accounting Officer
April 22, 2021 at 08:00 am EDT
Share
Novo Integrated Sciences, Inc. appointed Sterling Jimenez, Ph.D., as the principal accounting officer. Dr. Jimenez, age 46, also serves as the Vice-President, Finance for Novo Healthnet Limited, a wholly owned subsidiary of the Company. Dr. Jimenez brings over 25 years of international corporate finance and operational experience, which includes directing accounting and finance functions, corporate financial planning and analysis, risk modelling, valuation, mergers and acquisitions, cash flow management, internal and external reporting, and the ongoing evaluation and analysis of corporate financial activity. From 2020 to 2021, Dr. Jimenez served as the Director, Finance and Operations at Acenzia Inc., a Health Canada and FDA licensed nutraceuticals and supplements manufacturer. From 2018 to late 2019, Dr. Jimenez served as the Senior Business Analyst for risk, valuation, marketing, and operations at LiveWell Foods Inc. Canada, a nutraceuticals, CBD, and food manufacturing distribution company.
Novo Integrated Sciences, Inc. is a parent company to its subsidiaries. The Company owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.
NOVO INTEGRATED SCIENCES, INC. 